Shulman De Meo Asset Management LLC Moderna, Inc. Transaction History

Shulman De Meo Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$126.46 - $235.05 $109,134 - $202,848	-863 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$225.82 - $368.51 $194,882 - $318,024	863 New	863 $219,000
Q3 2021 Oct 26, 2021	SELL	$221.9 - $484.47 $203,926 - $445,227	-919 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$129.91 - $234.98 $119,387 - $215,946	919 New	919 $216,000
Q1 2021 Apr 26, 2021	SELL	$109.18 - $185.98 $211,809 - $360,801	-1,940 Closed	0 $0

Q4 2020 Jan 13, 2021	BUY	$65.74 - $169.86 $127,535 - $329,528	1,940 New	1,940 $203,000

1,039

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Shulman De Meo Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Shulman De Meo Asset Management LLC with notifications on news.